Cutera, Inc. (NASDAQ:CUTR) EVP Larry Laber sold 1,250 shares of the stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $44.30, for a total value of $55,375.00. Following the sale, the executive vice president now directly owns 70,463 shares of the company’s stock, valued at $3,121,510.90. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Larry Laber also recently made the following trade(s):

  • On Wednesday, November 8th, Larry Laber sold 1,700 shares of Cutera stock. The stock was sold at an average price of $42.15, for a total value of $71,655.00.
  • On Monday, November 6th, Larry Laber sold 500 shares of Cutera stock. The stock was sold at an average price of $41.50, for a total value of $20,750.00.
  • On Monday, October 16th, Larry Laber sold 500 shares of Cutera stock. The stock was sold at an average price of $40.50, for a total value of $20,250.00.

Cutera, Inc. (CUTR) traded up $0.05 on Friday, hitting $42.50. The stock had a trading volume of 333,803 shares, compared to its average volume of 237,341. The firm has a market cap of $588.84, a PE ratio of 54.49, a P/E/G ratio of 1.84 and a beta of 0.49. Cutera, Inc. has a 1-year low of $14.45 and a 1-year high of $47.15.

Cutera (NASDAQ:CUTR) last posted its quarterly earnings results on Tuesday, November 7th. The medical device company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.08 by $0.34. The business had revenue of $38.17 million during the quarter, compared to analysts’ expectations of $34.82 million. Cutera had a return on equity of 18.73% and a net margin of 7.99%. The company’s quarterly revenue was up 26.1% compared to the same quarter last year. During the same period last year, the firm earned $0.12 EPS. research analysts predict that Cutera, Inc. will post 0.55 earnings per share for the current fiscal year.

Cutera announced that its board has approved a stock repurchase plan on Monday, August 7th that allows the company to repurchase $25.00 million in shares. This repurchase authorization allows the medical device company to repurchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.

COPYRIGHT VIOLATION NOTICE: This story was first posted by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.watchlistnews.com/insider-selling-cutera-inc-cutr-evp-sells-55375-00-in-stock/1714356.html.

A number of analysts have weighed in on the company. Maxim Group reaffirmed a “hold” rating on shares of Cutera in a research report on Wednesday, November 8th. Zacks Investment Research cut Cutera from a “buy” rating to a “hold” rating in a research report on Tuesday, October 10th. Roth Capital increased their price objective on Cutera from $41.00 to $47.00 and gave the stock a “buy” rating in a research report on Tuesday, September 12th. TheStreet raised Cutera from a “c” rating to a “b” rating in a research report on Friday, August 18th. Finally, BidaskClub raised Cutera from a “hold” rating to a “buy” rating in a research report on Saturday, August 12th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Cutera currently has an average rating of “Buy” and an average target price of $37.33.

Institutional investors and hedge funds have recently bought and sold shares of the company. Parallel Advisors LLC acquired a new stake in shares of Cutera in the 3rd quarter valued at approximately $117,000. American International Group Inc. lifted its holdings in shares of Cutera by 7.0% in the 1st quarter. American International Group Inc. now owns 7,221 shares of the medical device company’s stock valued at $149,000 after buying an additional 475 shares during the period. Legal & General Group Plc lifted its holdings in shares of Cutera by 69.6% in the 3rd quarter. Legal & General Group Plc now owns 3,600 shares of the medical device company’s stock valued at $149,000 after buying an additional 1,477 shares during the period. Nationwide Fund Advisors lifted its holdings in shares of Cutera by 8.4% in the 2nd quarter. Nationwide Fund Advisors now owns 7,216 shares of the medical device company’s stock valued at $187,000 after buying an additional 561 shares during the period. Finally, Metropolitan Life Insurance Co. NY acquired a new stake in shares of Cutera in the 1st quarter valued at approximately $202,000. 89.72% of the stock is owned by institutional investors and hedge funds.

About Cutera

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Insider Buying and Selling by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.